Clinical Outcomes From NOCD Treatment of Obsessive-Compulsive Disorder Using Exposure and Response Prevention
Completed
- Conditions
- Obsessive-Compulsive Disorder
- Registration Number
- NCT04701372
- Lead Sponsor
- NOCD
- Brief Summary
This is a naturalistic, observational study of individuals with obsessive-compulsive disorder who were treated with exposure and response prevention via video teletherapy, augmented with between-session support with text messaging and an online community forum.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 2069
Inclusion Criteria
- obsessive-compulsive disorder
Exclusion Criteria
- none
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Dimensional Obsessive-Compulsive Scale change from pre-treatment to post-treatment (after 11 weeks) self-rated psychometric instrument to measure symptom severity of multiple OCD subtypes
- Secondary Outcome Measures
Name Time Method Diagnostic Interview for Anxiety, Mood, and OCD and Related Neuropsychiatric Disorders (DIAMOND) OCD severity scale pre-treatment, after 4 weeks, and post-treatment (after 11 weeks) clinician-rated psychometric instrument to measure overall OCD symptom severity
Depression Anxiety and Stress Scale (DASS-21) pre-treatment, after 4 weeks, and post-treatment (after 11 weeks) self-rated psychometric instrument to measure depression, anxiety, and stress
Quality of Life Enjoyment and Satisfaction Questionnaire -- Short Form (QLES-Q) pre-treatment, after 4 weeks, and post-treatment (after 11 weeks) self-rated psychometric instrument to measure quality of life
Trial Locations
- Locations (1)
Nocd, Llc
🇺🇸Chicago, Illinois, United States
Nocd, Llc🇺🇸Chicago, Illinois, United States